TAKE ON PH1
Live / Registered — Registered (as of 11 Oct 2022)
What this means for you
Registered since 11 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90683589
- Registration number
- 6869045
- Mark type
- Design + words
- Filed
- 30 Apr 2021
- Published for opposition
- 26 Jul 2022
- Registered
- 11 Oct 2022
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness about primary hyperoxaluria among affected individuals and their families
- Class 041 — Education and entertainment services: Educational services, namely, providing education information for training medical professionals and patients regarding primary hyperoxaluria
- Class 044 — Medical, beauty and agricultural services: Providing medical information about primary hyperoxaluria
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2022 — PUBLISHED FOR OPPOSITION
- 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Dec 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Dec 2021 — NON-FINAL ACTION E-MAILED
- 18 Dec 2021 — NON-FINAL ACTION WRITTEN